Eisai Inc. (ESALF.PK): Results From Phase II Trial in Critical Care Medicine Showed Eritoran Tetrasodium (E5564) To Be Well Tolerated in Patients with Severe Sepsis 12/22/2009
More...
|
Milk Protein Supplement Prevents Sepsis in Preterm Infants, S. Anna Hospital Study 10/7/2009
More...
|
bioMerieux SA: Clinicians Report Tools to Monitor the Progression of Sepsis Urgently Needed 5/7/2009
More...
|
SIRS-Lab GmbH Appoints Ania Mitan as Executive VP Commercial Expanding its Senior Management to Further Accelerate the Commercialization of its Unique Sepsis Diagnostics Suite 12/11/2008
More...
|
SIRS-Lab GmbH Receives ISO Certification for Molecular in-vitro Sepsis Diagnostics 10/16/2008
More...
|
Uscom Limited Monitor Improves Management Of Children With Septic Shock 10/8/2008
More...
|
Cook Medical And Thomas Jefferson University Release: Roundtable Summit To Formulate Recommendations For The Prevention Of Line Sepsis 9/25/2008
More...
|
SIRS-Lab GmbH Pre-Announces Biomarker Based Sepsis Test 7/1/2008
More...
|
Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis 4/22/2008
More...
|
Spectral Diagnostics (SDI.TO)'s EAA(TM) to be Used in Phase III Study for a Sepsis Anti-Endotoxin Therapy 4/9/2008
More...
|
Potential Drug Targets For Sepsis Discovered by The Scripps Research Institute Researchers 2/29/2008
More...
|
Protherics PLC Release: CytoFabTM Phase 2 Programme in Severe Sepsis Commenced by AstraZeneca PLC (AZN) 1/22/2008
More...
|
Rules-Based Medicine, Inc. Medicine Awarded $849,000 Grant by the National Institutes of Health (NIH) 11/15/2007
More...
|
Results of Pre-Clinical Investigation of Ceragenix Pharmaceuticals, Inc. (CGXP.OB)'s Developmental Antibiotic to Prevent Sepsis Presented at International Scientific Meeting 10/22/2007
More...
|
MedaSorb Technologies (MSBT.OB) Completes Key Step to Begin Clinical Study in Europe for CytoSorb(TM) in the Treatment of Sepsis 10/17/2007
More...
|
GATC Biotech Announces Collaboration Agreement to Develop Comprehensive DNA-Based Sepsis Diagnostic 9/25/2007
More...
|
Spectral Diagnostics (SDI.TO) Partner Launches EAA(TM) Rapid Sepsis Diagnostic in Germany 9/20/2007
More...
|
Artisan Pharma, Inc. Launches Phase 2b Trial of ART-123 for the Treatment of DIC in Sepsis 8/21/2007
More...
|
Hospital Using Royal Philips Electronics N.V. (PHG) Clinical Decision Support to Help Detect and Treat Sepsis Earlier 5/22/2007
More...
|
Biosite Incorporated (BSTE) Reports on Presentation of Preliminary Data From Sepsis Program 3/28/2007
More...
|
Eli Lilly and Company (LLY) Plans New Clinical Trial of Xigris(R) 2/26/2007
More...
|
NanoLogix, Inc. (IFEC) Applies For Provisional Patent Application For Innovative Treatment Of Severe Sepsis 2/20/2007
More...
|
Cepheid (CPHD) And bioMerieux, Inc. Enter Into Strategic Agreements To Develop And Market Sepsis And MRSA Products 1/17/2007
More...
|
BioVeris Corporation (BIOV) Completes New Vaccine License 12/27/2006
More...
|
SIRS-Lab GmbH Successfully Completes A Milestone For The Development Of Early Diagnosis Tests For Sepsis 11/16/2006
More...
|
Protherics PLC And AstraZeneca PLC (AZN) Updates CytoFab(TM) Development Programme; New Trial To Delay Drug 11/3/2006
More...
|
Adenosine Therapeutics Awarded Phase II SBIR Grant To Treat Asthma And STTR Grant To Develop New Treatment For Sepsis 10/26/2006
More...
|
Dutch Biopharmaceutical Company AM-Pharma Holding BV Announces Positive Results In Its Double-Blind, Placebo Controlled Phase IIa Sepsis Trial With Alkaline Phosphatase 10/20/2006
More...
|
National Institutes of Health (NIH): Eli Lilly and Company (LLY) Influenced Sepsis Treatment 10/19/2006
More...
|
GTC Biotherapeutics (GTCB) Reports Second Quarter 2006 Financial Results; European Medicines Evaluation Agency Provides Scientific Advice On The Study Of ATryn(R) In DIC 8/3/2006
More...
|
Spectral Diagnostics (SDI.TO) Announces Distribution Agreement For Endotoxin Activity Assay (EAA(TM)) With Estor, SpA, In Italy 6/23/2006
More...
|
New Study Finds Key Role For VEGF In Onset Of Sepsis 5/19/2006
More...
|
Protherics PLC Announces Agreement With AstraZeneca (AZN); Protherics To Receive £16.3 Million 1/12/2006
More...
|
Eli Lilly and Company's (LLY) Sepsis Drug Fails To Help Patients At Low Risk Of Death 9/29/2005
More...
|
MultiCell Technologies Inc. (MUCL.OB) Receives SBIR Grant For Protein Development For Critically Needed Sepsis Treatment 8/30/2005
More...
|
Eisai Company, Ltd. (ESALY.PK) Announce Phase II Results, Plans To Initiate Phase III Clinical Trial Program For Eritoran As A Treatment For Severe Sepsis 8/29/2005
More...
|
Nanogen, Inc. (NGEN) Awarded $2.5 Million Grant For Development Of Diagnostics For Sepsis And Pneumonia 8/1/2005
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Receives FDA Fast Track Designation For TAK-242, Investigational Compound For Severe Sepsis 7/29/2005
More...
|
GenoSept - To Trace the Genetic Causes Of Sepsis; SIRS-Lab GmbH Participates In An European Research Project Focussed On The Genetics Of Sepsis 5/24/2005
More...
|
Protein Prevents Detrimental Immune Effects Of Bacterial Sepsis 5/23/2005
More...
|
Eli Lilly and Company (LLY) Stops Pediatric Trial Of Sepsis Drug 4/29/2005
More...
|
Hollis-Eden Pharmaceuticals Inc. (HEPH) Announces Potent, Second-Generation Compounds Provide Significant Therapeutic Benefit In Preclinical Models Of Lung Inflammation, Septic Shock And Multiple Sclerosis 4/5/2005
More...
|
Signet Laboratories, Inc. Announces Availability Of P504s IVD Monoclonal Antibody For Prostate Cancer Detection 11/2/2004
More...
|
Signet Laboratories, Inc. To Develop Predictive Diagnostics And Preventive Therapeutics For Treating Sepsis And Acute Renal Failure (S/ARF) 7/21/2004
More...
|
Medical Discoveries (MLSC) Files Patent Application On Sepsis 4/14/2004
More...
|
Signet Laboratories, Inc. Announces Receipt Of "Notice of Allowance" In Europe For Patents Protecting Their Sepsis And Renal Failure Assay Technology 3/22/2004
More...
|
Medical Discoveries (MLSC) Announces Receipt Of Sepsis Pre-Clinical Report On MDI-P 3/18/2004
More...
|
Edwards Lifesciences (EW) Release: New International Guidelines Support Early Goal Directed Therapy To Treat Sepsis 2/25/2004
More...
|
CytoGenix, Inc. (CYGX) Announces Research Agreement With University of Texas Health Science Center Houston For Pre-Clinical Testing Of A Gene-Silencing Anti-Bacterial Agent Against Sepsis 12/15/2003
More...
|
CytoGenix, Inc. (CYGX) Announces Acceptance For Publication By Prestigious Scientific Journal, Data Shows The Effectiveness Of its Novel Anti-bacterial Agent 11/13/2003
More...
|